The global epidemic is facing the double test of COVID-19 and monkeypox. Affected by the Omicron subtypes BA.4 and BA.5, the global epidemic situation has once again rebounded. WHO Director-General Tedros Adhanom Ghebreyesus said that the global epidemic is still not optimistic.

2024/05/2608:19:33 international 1951

The global epidemic is facing the double test of COVID-19 and monkeypox. Affected by the Omicron subtypes BA.4 and BA.5, the global epidemic situation has once again rebounded. WHO Director-General Tedros Adhanom Ghebreyesus said that the global epidemic is still not optimistic.  - DayDayNews

The global epidemic is facing the double test of new crown and monkeypox .


is affected by the Omicron subtypes BA.4 and BA.5, and the global epidemic situation has once again rebounded. Director-General of WHO Tedros Adhanom Ghebreyesus said that the global epidemic is still not optimistic. The BA.4 and BA.5 strains have caused the total number of new cases worldwide to increase by 20%, with up to 110 countries and regions showing an upward trend. On the evening of July 4, local time, Singaporean President Halimah Yacob and Singapore Parliament Speaker Chen Chuanren successively stated that they had been diagnosed with the new coronavirus.


At the same time, the monkeypox epidemic in the United States suddenly issued a strong warning. On July 3, local time, the US "Capitol Hill" reported that American infectious disease experts and public health advocates warned that the Biden administration's response to the monkeypox epidemic was too slow and that the monkeypox epidemic in the United States could get out of control.


In response to the continued growth of monkeypox epidemics in Europe and the United States, the National Health Commission recently released the "Technical Guidelines for Monkeypox Prevention and Control (2022 Edition)" mentioned that during the quarantine period for existing inbound travelers, while checking for new coronavirus infection, various regions People entering the country should be proactively screened for monkeypox virus. Stimulated by a series of news, A-share monkeypox concept stocks continued to rise on July 4. As of the close, the monkeypox index rose by more than 5%.


Singapore’s President confirmed


On the evening of July 4, local time, Singaporean President Halimah Yacob revealed on social media that she had been diagnosed with the new coronavirus and her current symptoms were mild. In addition, Singaporean Parliament Speaker Chen Chuanren also posted that he was diagnosed with the virus during a test before the parliamentary meeting. He currently has cold symptoms and is in good condition. He also reminded the public to continue to be vigilant and get vaccination booster shots.


is affected by the Omicron subtypes BA.4 and BA.5, and Singapore has seen a counterattack in the epidemic situation. At the end of June, the number of new confirmed cases in Singapore in a single day once exceeded 10,000, setting a new high since March this year, and the weekly infection rate skyrocketed.


Singapore’s Health Minister Ong Ye Kung said that the next wave of new crown infections in Singapore came earlier than expected, and the surge in local infections was mainly driven by the Omicron subtypes BA.4 and BA.5. He predicts there will be more waves of the virus driven by new variants in the future.


The global epidemic has also shown a new round of rebound. The latest global epidemic weekly report released by the World Health Organization (WHO) shows that the more contagious Omicron BA.4 and BA.5 have become the main strains. WHO Director-General Tedros Adhanom Ghebreyesus said that the global epidemic is still not optimistic. The BA.4 and BA.5 strains have led to a 20% increase in the total number of new cases worldwide, with up to 110 countries and regions showing an upward trend.


Among them, the United States has had more than 3 million new confirmed cases in the past 28 days, and 9,111 new deaths in the past 28 days, both the highest in the world; the situation in the United Kingdom is not optimistic either, Jenny Harry, CEO of the British Health Security Agency Si said on July 3 that the number of COVID-19 hospitalizations in the UK is likely to increase in the next few weeks to exceed the peak level in April this year; German health department officials warned that with the spread of the Omicron strain With the spread of the new subtype BA.5, Germany will face a "difficult autumn" and it is recommended to introduce a mandatory "indoor mask order" again.


There is a risk of getting out of control


The monkeypox epidemic in the United States suddenly issued a strong warning.


On July 3, local time, the US "Capitol Hill" reported that American infectious disease experts and public health advocates warned that the Biden administration's response to the monkeypox epidemic was too slow and that the United States may lose control of the monkeypox epidemic.


"Capitol Hill" stated that according to data from the U.S. Centers for Disease Control and Prevention (CDC), monkeypox cases have been found in 30 states, Puerto Rico and the District of Columbia, with a total of 460 cases in the United States. However, American infectious disease experts believe that this number is obviously an underestimate because the number of monkeypox tests in the United States is too small, resulting in many potentially infected people having no chance to be tested.


This report interviewed many experts in the field of infectious diseases and public health in the United States. Most experts said that the U.S. government’s response to monkeypox was like the worst part of the early stages of the new crown epidemic, with severely limited testing and slow vaccine rollout. Allowing the virus to spread undetected.


Among them, David Harvey, executive director of the National Council of Directors of Sexually Transmitted Diseases (NCSD), pointed out that the US government is "bureaucratic" and "slow" in simplifying testing, providing vaccines, and simplifying access to the best treatment. "This means that the United States may not be able to control the epidemic.


In addition, James Krellenstein, co-founder of HIV treatment advocacy organization Prep4All, criticized the poor monkeypox testing situation in the United States in the past month. This is an obvious mistake that could have been prevented. Clearly, the government has not learned the lessons of the early coronavirus outbreak.


In late June this year, the U.S. government officially authorized commercial laboratories to carry out monkeypox testing to improve the detection capacity of monkeypox virus. However, this move will take up to a month to increase the U.S. testing capacity from 8,000 to 8,000 per week. times increased to 10,000 times per week. This obviously cannot satisfy the large number of potential suspected patients, causing the monkeypox epidemic to continue to spread covertly.


It should be pointed out that the sampling process for monkeypox detection is relatively simple, as long as the skin lesions are wiped. And unlike the new coronavirus, the U.S. Centers for Disease Control and Prevention already has a relatively mature testing method, but those participating in testing must meet a series of standards to qualify for testing.


In this regard, Dr. Celine Gond, an American epidemiologist and Kaiser Health News special editor, said that commercial laboratories should have been involved earlier and should have been more active and rapid in testing. The current situation also shows that The bureaucracy of the US Food and Drug Administration and the US Centers for Disease Control and Prevention.


Monkeypox vaccine plan, too late?


However, in the face of the monkeypox epidemic in the United States, the Biden administration is very optimistic. White House coronavirus response coordinator Ashish Jha said at a recent meeting that monkeypox is very different from the new coronavirus. It is not new and is not as highly contagious as the new coronavirus. , the United States has a vaccine against monkeypox.


Currently, the Biden administration is planning to respond to the monkeypox epidemic by expanding vaccinations. But critics say these efforts may come too late.


The White House announced that it will distribute tens of thousands of third-generation smallpox vaccine Jynneos. The current inventory is about 350,000 doses. The 300,000 doses purchased will be sent from Denmark within a few days. A total of 1.6 million doses are expected to be available this year. vaccine.


However, in fact, after monkeypox vaccination appointments were opened in New York City and Washington, DC, all the vaccines were "snatched" in less than a day, and the official website for appointments had to close access after 10 minutes.


According to a report by "Capitol Hill" on the 3rd, U.S. officials said that approximately 56,000 doses of monkeypox vaccine in the U.S. National Strategic Reserve will be distributed immediately, and the government plans to distribute 296,000 doses of vaccine in the next few weeks. According to a spokesman for Danish vaccine manufacturer Bavarian Nordic, 300,000 doses of vaccine have been delivered or will be delivered in the next few days.


Jon Andrus, associate professor at the Milken Institute School of Public Health at George Washington University, said that the United States will continue to repeat the mistakes of the new crown epidemic because it has experienced more than five waves of the new crown epidemic, each time it seems to be starting from scratch, and each time it seems to be caught off guard.


Over 6,100 confirmed cases of monkeypox worldwide


As of July 2, 67 countries outside Central and West Africa have reported a total of 6,178 confirmed cases of monkeypox and 51 suspected cases. Among them, the United Kingdom, Spain, and Germany are the three countries with the largest number of confirmed cases, with 1,235, 1,196, and 1,054 cases respectively.


Currently, this round of monkeypox epidemic mainly occurs in Europe and North America. The total number of confirmed cases in Europe has reached 5,262, and the number of confirmed cases in North America has reached 692. On June 21, Singapore confirmed its first imported case of monkeypox. The monkeypox epidemic Introduced to Asia.


According to the United Nations official website, WHO European Regional Director Krueger said on July 1 that Europe constitutes the center of the monkeypox epidemic. Since mid-May, the monkeypox cases reported by the WHO European Region accounted for 10% of all monkeypox cases. Nearly 90% of laboratory-confirmed and globally reported cases, with cases tripling in the past 2 weeks.


Judging from the growth rate of monkeypox cases, on July 1, 707 new cases were diagnosed, and the average number of confirmed cases per day in the past seven days was 291.5, which is in an accelerated growth stage.


This current round of monkeypox epidemic is unusual compared to past historical situations. It spreads quickly and the chain of transmission is still unclear. At the same time, genetic sequencing results show that the virus has nearly 50 mutations. Subsequent developments deserve close attention.


Tedros said at a press conference on June 29 that he had adopted the recommendations of the Emergency Committee and would convene a meeting as soon as possible to assess the rapidly evolving situation of monkeypox transmission.


Regarding the continued growth of monkeypox epidemics in Europe and the United States, the National Health Commission released the "Technical Guidelines for Monkeypox Prevention and Control (2022 Edition)" on July 1. It is mentioned that during the quarantine period of existing inbound travelers, while checking for new coronavirus infection, all localities should take the initiative to screen for monkeypox virus on inbound travelers, especially those who have a history of traveling to countries with monkeypox epidemic reports within 21 days before entry, and closely monitor them. In case of rash, if suspicious persons or suspected cases are discovered, they should be reported to the disease control agency in the jurisdiction in a timely manner in accordance with relevant regulations and transferred to a designated medical institution for treatment.


Stimulated by a series of news, A-share monkeypox concept stocks continued to rise on July 4. As of the close, the monkeypox index soared by more than 5%. Among them, Zhijiang Biotech rose by 15.7% in a single day, Lanwei Medical rose by more than 12%, Jiangsu Wuzhong rose by the limit, Oriental Biotech rose by more than 7%, and Shuoshi Biotech rose by more than 5%.


Zhongtai Securities said that considering the occurrence of monkeypox epidemics in many European and American countries and the superimposed risk of domestic import, attention is paid to the development of test kits and treatment and other related targets.

Editor: Tactics Heng
Original title: Sudden! The President of Singapore has been diagnosed with COVID-19, and the monkeypox epidemic may be out of control in the United States! Biden criticized: action is too slow! How big is the impact of concept stocks soaring?

Source: Brokerage market conditions

international Category Latest News

On July 7, Zhang Anshun, member of the Standing Committee of the Provincial Party Committee, Secretary of the Municipal Party Committee, and Director of the Foreign Affairs Working Committee of the Municipal Party Committee, presided over the third plenary meeting of the Foreign  - DayDayNews

On July 7, Zhang Anshun, member of the Standing Committee of the Provincial Party Committee, Secretary of the Municipal Party Committee, and Director of the Foreign Affairs Working Committee of the Municipal Party Committee, presided over the third plenary meeting of the Foreign

Zhang Anshun emphasized at the third plenary meeting of the Municipal Party Committee’s Foreign Affairs Committee: Promoting high-quality economic and social development of the city with high-quality and efficient foreign affairs work Zhang Qixiang attended